DWC202216
Sponsors
Daewoong Pharmaceutical Co. LTD.
Conditions
Healthy Volunteers
Phase 1
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers
NCT05954247
Start: 2023-08-01End: 2023-12-01Target: 24Updated: 2023-07-24
Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers
NCT05954338
Start: 2023-08-01End: 2023-12-01Target: 52Updated: 2023-07-24